An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) (FIBRONEER-ON)

153001305-0031OpenAn open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) (FIBRONEER-ON)NCT06238622IndustrialAdultTreatmentIIIOtherFleury, ChristineGeorgetown University Medical Center : Amen Hamed; Lombardi Comprehensive Cancer Center : Amen HamedGUMC Medicine Pulmonary; GUMC PFS9081Amen HamedAmen Hamedamen.m.hamed@gunet.georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>